Meditation for the primary and secondary prevention of cardiovascular disease

Rees, Karen; Takeda, Andrea; Court, Rachel; Kudrna, Laura; Hartley, Louise; Ernst, Edzard

doi:10.1002/14651858.cd013358.pub2

Cited by 3 publications

(1 citation statement)

References 199 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, stress-reduction techniques have been shown to reduce stress perception while improving some downstream manifestations of stress, including reducing hypertension while enhancing microvascular function. 18,19 The impact of such interventions on MSIMI as well as coronary microvascular dysfunction could be further examined. Moreover, it would be attractive to further study interventions targeting downstream components of heart-brain mechanisms.…”

Section: See Article By Osei Et Almentioning

confidence: 99%

Stressing the Importance of Autonomic Nervous System Dysfunction

Bellinge,

Tawakol

2024

Circ: Cardiovascular Imaging

View full text Add to dashboard Cite

Section: See Article By Osei Et Almentioning

confidence: 99%

Stressing the Importance of Autonomic Nervous System Dysfunction

Bellinge,

Tawakol

2024

Circ: Cardiovascular Imaging

View full text Add to dashboard Cite

The promising role of Transcendental Meditation in the prevention and treatment of cardiometabolic diseases: A systematic review

Khanal,

Karimi,

Saunders

et al. 2024

Obesity Reviews

View full text Add to dashboard Cite

SummaryPsychological distress has a demonstrable impact on cardiovascular diseases (CVD) and risk factors. Transcendental Meditation (TM) has been shown to reduce stress and improve health and well‐being. The current review aimed to synthesize the evidence on the effects of TM on cardiometabolic outcomes and identify gaps for future research. We searched PubMed/MEDLINE, EMBASE, SCOPUS, and Web of Science databases for relevant literature. Forty‐five papers that reported studies of TM on cardiometabolic risk factors and diseases were included. Evidence shows that TM is effective in reducing blood pressure (BP). We found some evidence that TM can improve insulin resistance and may play a role in improving dyslipidemia, exercise tolerance, and myocardial blood flow, and in reducing carotid intima‐media thickness and left ventricular mass. Studies show that long‐term TM practice can reduce the risk of myocardial infarction, stroke, and CVD mortality. This review identified that certain studies have high participant drop‐out rates, and fewer studies targeted comprehensive cardiometabolic outcomes beyond BP with longer follow‐up periods. We found that most studies were conducted in specific populations, which may limit generalizability. In conclusion, TM has the potential to improve cardiometabolic health; however, research gaps highlight the need for larger phase III multicenter clinical trials with long‐term follow‐ups.

show abstract